Balance Sheet
AssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent Deferred RevenueLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Enact Holdings (ACT) Cash & Equivalents (2020 - 2025)

Enact Holdings (ACT) has 6 years of Cash & Equivalents data on record, last reported at $582.5 million in Q4 2025.

  • For Q4 2025, Cash & Equivalents fell 2.83% year-over-year to $582.5 million; the TTM value through Dec 2025 reached $582.5 million, down 2.83%, while the annual FY2025 figure was $582.5 million, 2.83% down from the prior year.
  • Cash & Equivalents reached $582.5 million in Q4 2025 per ACT's latest filing, up from $543.6 million in the prior quarter.
  • Across five years, Cash & Equivalents topped out at $699.0 million in Q2 2024 and bottomed at $425.8 million in Q4 2021.
  • Average Cash & Equivalents over 5 years is $584.3 million, with a median of $606.2 million recorded in 2024.
  • Peak YoY movement for Cash & Equivalents: skyrocketed 41.23% in 2023, then fell 19.27% in 2025.
  • A 5-year view of Cash & Equivalents shows it stood at $425.8 million in 2021, then increased by 20.65% to $513.8 million in 2022, then increased by 19.84% to $615.7 million in 2023, then decreased by 2.64% to $599.4 million in 2024, then decreased by 2.83% to $582.5 million in 2025.
  • Per Business Quant database, its latest 3 readings for Cash & Equivalents were $582.5 million in Q4 2025, $543.6 million in Q3 2025, and $613.0 million in Q2 2025.